Maldonado v. GeneDx

2024 COA 121
Colorado Court of Appeals·Decided November 21, 2024·No. 23CA2092·Published·Cited by 1 cases

Opinion

The summaries of the Colorado Court of Appeals published opinions constitute no part of the opinion of the division but have been prepared by the division for the convenience of the reader. The summaries may not be cited or relied upon as they are not the official language of the division. Any discrepancy between the language in the summary and in the opinion should be resolved in favor of the language in the opinion.

SUMMARY

November 21, 2024

2024COA121

No. 23CA2092, Maldonado v. GeneDx — Health and Welfare — Health Care Availability Act — Limitation of Actions — Genetic Testing and Counseling

A division of the court of appeals interprets for the first time section 13-64-502(1), C.R.S. 2024, holding that the parents alleged a plausible claim for relief against medical professionals and health care institutions for damages arising from allegedly negligent genetic testing and counseling that could have prevented or avoided the birth of twins with a medical disorder if the professionals and institutions had exercised the ordinary standard of care. As a result, the division reverses the district court’s dismissal of the parents’ claims under C.R.C.P. 12(b)(5).

COLORADO COURT OF APPEALS 2024COA121

Court of Appeals No. 23CA2092 City and County of Denver District Court No. 23CV31908 Honorable Martin F. Egelhoff, Judge

Secily Maldonado, individually, and as next friends, natural parents, and guardians of their son JAC, a minor, and their daughter JMC, a minor child, John Anthony Carcanaques, individually, and as next friends, natural parents, and guardians of their son JAC, a minor, and their daughter JMC, a minor child, J.A.C., individually by and through their guardians and custodians Secily Maldonado and John Anthony Carcanaques, and J.M.C., individually by and through their guardians and custodians Secily Maldonado and John Anthony Carcanaques,

Plaintiffs-Appellants, v.

GeneDx, Inc., a New Jersey corporation; GeneDx, LLC; a Non-Maryland limited liability company; Katelyn Beattie, MSG, CGC; Amanda Lindy, FACMG, PhD; Children’s Hospital of Colorado, a Colorado nonprofit corporation; Alison Ballard, RN, CPNP; Melissa Gibbons, MS, Genetic Counselor; Lisa McCown, MS, Genetic Counseling Graduate Student; and University of Colorado Hospital Authority located at Anschutz Campus,

Defendants-Appellees.

JUDGMENT AFFIRMED IN PART, REVERSED IN PART, AND CASE REMANDED WITH DIRECTIONS

Division II

Opinion by JUDGE JOHNSON

Fox and Schock, JJ., concur

Announced November 21, 2024

Chalat Hatten & Banker, PC, James H. Chalat, Evan P. Banker, Denver, Colorado; Purvis Thompson, LLP, John A. Purvis, Michael J. Thompson, Boulder, Colorado, for Plaintiff-Appellants

Taylor Anderson LLP, John T. Osgood, James D. Murdock, II, Benjamin Wright, Christine L. Atwood, Denver, Colorado, for Defendants-Appellees GeneDx, Inc.; GeneDx, LLC; Katelyn Beattie; and Amanda Lindy

Hall Booth Smith, P.C., Elizabeth C. Moran, Rodrigo Lugo, Greenwood Village, Colorado; Hall Booth Smith, P.C., Ryan M. Donihue, Atlanta, Georgia for Defendant-Appellee Children’s Hospital of Colorado

Conklin Cardone & Rutberg, PC, John Conklin, Deann Zenisek, Denver, Colorado for Defendants-Appellees Alison Ballard, Melissa Gibbons, Lisa McCown, and University of Colorado Hospital Authority

¶1 In 1988, the General Assembly enacted the Health Care Availability Act (HCAA), effective July 1, 1988. See §§ 13-64-101 to -503, C.R.S. 2024. Currently, and as originally passed, section 13- 64-502(1), C.R.S. 2024, limits the scope of liability in certain negligence actions against health care professionals. There is, however, an exception. As originally passed, the exception authorized lawsuits for “injury” that could have been “prevented or avoided” had the health care professional acted consistent with the ordinary standard of care. § 13-64-502, C.R.S. 1988 (repealed 1989).

¶2 Approximately five months after the HCAA’s enactment, our supreme court decided Lininger v. Eisenbaum, 764 P.2d 1202, 1204 (Colo. 1988). The case recognized a common law negligence action seeking damages against a doctor who provided the parents with medical advice that their first child’s eye condition resulting in blindness was not genetic, yet their second child developed the same eye condition as his sibling.

¶3 Following Lininger, the General Assembly amended section 13- 64-502(1), effective July 1, 1989, by broadening the statutory bar against negligence actions to preclude claims for “damage or injury”

arising from “genetic counseling and screening” but also expanding the exception to permit lawsuits involving “damage or injury” resulting from a “genetic disease or disorder” that could have been prevented or avoided if the ordinary standard of care had been met. Ch. 135, sec. 4, § 13-64-502(1), 1989 Colo. Sess. Laws 763.

¶4 Since its enactment, no case has interpreted section 13-64- 502(1). Given the timing of this provision’s amendment in 1989, as well as the plain language of the statute, it is reasonable to interpret the provision consistent with Lininger’s holding. Specifically, we give effect to the term “damage” in the statute to permit a claim for economic damages for a child’s medical expenses or other extraordinary expenses resulting from a health care professional’s alleged negligent genetic counseling or screening.

¶5 In this case, the parents brought an action against medical professionals alleging that negligent genetic testing and counseling led them to believe their twins would not be — but were in fact — affected by a severe medical disorder. The district court dismissed the parents’ claims under C.R.C.P. 12(b)(5), reasoning that the lawsuit did not fall under section 13-64-502(1)’s exception. But the parents’ claims do fall squarely under that exception, so we reverse

and reinstate the complaint as to those claims. As to the children’s claims against the medical professionals, however, we conclude that the district court properly dismissed them under Lininger. And we decline to address damages because the issue was not resolved below. Therefore, we reverse in part, affirm in part, and remand the case to the district court for further proceedings consistent with this opinion.

I. Background

¶6 Plaintiffs Secily Maldonado (Maldonado) and John Anthony Carcanaques (Carcanaques) (collectively the parents) brought this action on behalf of themselves and on behalf of their twins, plaintiffs J.A.C. and J.M.C. (collectively the children), who also asserted claims on behalf of themselves. The complaint alleged that defendants — who include the Children’s Hospital of Colorado, the University of Colorado Hospital Authority, Alison Ballard (Ballard), Melissa Gibbons (Gibbons), and Lisa McCown (McCown) (collectively, Hospital Defendants) as well as GeneDx, Inc.; GeneDx, LLC; Katelyn Beattie (Beattie); and Amanda Lindy (Lindy) (collectively GeneDx Defendants) — negligently misrepresented to Maldonado that she was not a genetic carrier of Duchenne

Muscular Dystrophy (DMD) and that the parents relied on that information and Maldonado ultimately gave birth to J.A.C. (who has developed DMD) and J.M.C. (who is a carrier of DMD).

¶7 Based on the allegations in the complaint, DMD is an inheritable and irreversible genetic disorder that is marked by progressive muscle degeneration and weakness. The disease is an X-linked recessive gene disorder that predominantly affects males (females are usually carriers without displaying symptoms). Due to its genetic nature, the presence of DMD in a family history significantly increases the risk of occurrence in offspring, reinforcing the importance of genetic counseling and testing in families with known carriers.

Free access — add to your briefcase to read the full text and ask questions with AI

Maldonado v. GeneDx, 2024 COA 121 (Colo. Ct. App. 2024).

2024 COA 121 (Maldonado v. GeneDx) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Maldonado v. GeneDx
2024 COA 121 (Colorado Court of Appeals, 2024)